Next Article in Journal
Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies
Previous Article in Journal
Genome-Wide Analysis of Flax (Linum usitatissimum L.) Growth-Regulating Factor (GRF) Transcription Factors
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 23
10.3390/ijms242317108
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2018, 19(11), 3592.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592

by
Irene del Molino del Barrio
1,
Georgina C. Wilkins
1,
Annette Meeson
2,
Simi Ali
1,* and
John A. Kirby
1
1
Applied Immunobiology and Transplantation Group, Institute of Cellular Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK
2
Institute of Genetic Medicine, International Centre for Life, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 3BZ, UK
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(23), 17108; https://doi.org/10.3390/ijms242317108
Submission received: 3 November 2023 / Accepted: 15 November 2023 / Published: 4 December 2023
(This article belongs to the Section Biochemistry)
Browse Figure
Versions Notes
The authors and Editorial Office were made aware of an error in a figure within the original publication [1].
During the compilation of the images for this article, an error occurred whereby the incorrect images for Figure 1, “no primary” antibody control for Patient 1 and 2, were published. The authors provided the correct original image files to the Editorial Office, and Figure 1 has now been updated with the correct “no primary” Patient 1 and 2 images. The magnification is different for the Patient 1 and 2 no primary controls. The authors state that the scientific conclusions are unaffected. This correction process was supervised and approved by the Academic Editor.

Reference

  1. del Molino del Barrio, I.; Wilkins, G.C.; Meeson, A.; Ali, S.; Kirby, J.A. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592. [Google Scholar] [CrossRef] [PubMed]
Ijms 24 17108 g001
Figure 1. CXCR4 and ACKR3 staining using IHC in breast cancer tissue. Sections 4 μm in size from human breast cancer were stained for CXCR4 (1:40) and ACKR3 (1:100) using immunohistochemistry following no pre-treatment or EDTA antigen retrieval pre-treatment, respectively. Briefly, the protocol from the VECTASTAIN ABC HRP kit was followed; the signal was developed using DAB and counterstained with haematoxylin. No primary antibody was used as a control. n = 2, patient 1 control, scale bar = 100 μm; patient 2 control, scale bar = 200 μm.
Figure 1. CXCR4 and ACKR3 staining using IHC in breast cancer tissue. Sections 4 μm in size from human breast cancer were stained for CXCR4 (1:40) and ACKR3 (1:100) using immunohistochemistry following no pre-treatment or EDTA antigen retrieval pre-treatment, respectively. Briefly, the protocol from the VECTASTAIN ABC HRP kit was followed; the signal was developed using DAB and counterstained with haematoxylin. No primary antibody was used as a control. n = 2, patient 1 control, scale bar = 100 μm; patient 2 control, scale bar = 200 μm.
Ijms 24 17108 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

del Molino del Barrio, I.; Wilkins, G.C.; Meeson, A.; Ali, S.; Kirby, J.A. Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592. Int. J. Mol. Sci. 2023, 24, 17108. https://doi.org/10.3390/ijms242317108

AMA Style

del Molino del Barrio I, Wilkins GC, Meeson A, Ali S, Kirby JA. Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592. International Journal of Molecular Sciences. 2023; 24(23):17108. https://doi.org/10.3390/ijms242317108

Chicago/Turabian Style

del Molino del Barrio, Irene, Georgina C. Wilkins, Annette Meeson, Simi Ali, and John A. Kirby. 2023. "Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592" International Journal of Molecular Sciences 24, no. 23: 17108. https://doi.org/10.3390/ijms242317108

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop